We're sharing our nuc-BRET plasmids on Addgene! This assay measures GDP/GTP-dependent BRET signal changes as a proxy for affinities, which correlate with ligand efficacy at opioid receptor-G protein complexes. High sensitivity for low-efficacy partial agonists that slip through conventional assays.
